Rituxan (rituximab) - Roche
Nucala (mepolizumab) - GSK
Cardiac Manifestations of EGPA: An Overlap Phenotype of Inflammatory Myocardial Injury and Takotsubo-Like Syndrome. (PubMed, JACC Case Rep) - Oct 14, 2026 - "Cardiac involvement remains the leading cause of mortality in EGPA. This case highlights the heterogeneity of its cardiac phenotypes, illustrating the importance of early cardiology evaluation and diagnostics." 
Journal • Asthma • Cardiomyopathy • Cardiovascular • Chronic Cough • Cough • Eosinophilia • Eosinophilic Granulomatosis With Polyangiitis • Hodgkin Lymphoma • Immunology • Inflammation • Langerhans Cell Histiocytosis • Pulmonary Disease • Rare Diseases • Respiratory Diseases • Thrombosis • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42867423
 
Alison P Grisé; Bernard Shalit; Dustin G Shaw; Giancarlo Buonomo
 
Oct 14, 2026
 
Prev Next